Abivax S.A.
General ticker "AAVXF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.3B (TTM average)
Abivax S.A. follows the US Stock Market performance with the rate: 27.0%.
Estimated limits based on current volatility of 6.6%: low 71.64$, high 81.80$
Short-term AAVXF quotes
Long-term AAVXF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €4.62MM | €10.79MM | €0.00MM |
| Operating Expenses | €132.00MM | €183.78MM | €250.53MM |
| Operating Income | €-127.38MM | €-172.98MM | €-250.53MM |
| Non-Operating Income | €-24.86MM | €-3.26MM | €-82.66MM |
| Interest Expense | €13.83MM | €4.18MM | €28.50MM |
| R&D Expense | €103.18MM | €146.53MM | €177.69MM |
| Income(Loss) | €-152.23MM | €-176.24MM | €-333.19MM |
| Taxes | €-4.49MM | €0.00MM | €2.79MM |
| Net Income(Loss)* | €-147.74MM | €-176.24MM | €-335.98MM |
| Stockholders Equity | €196.01MM | €40.58MM | €455.03MM |
| Inventory | €0.14MM | €0.00MM | €0.00MM |
| Assets | €327.06MM | €205.23MM | €584.12MM |
| Operating Cash Flow | €-97.13MM | €-154.07MM | €-162.03MM |
| Capital expenditure | €0.27MM | €0.64MM | €0.14MM |
| Investing Cash Flow | €-8.10MM | €15.76MM | €-13.72MM |
| Financing Cash Flow | €335.29MM | €28.21MM | €553.59MM |
| Earnings Per Share** | €-3.43 | €-2.80 | €-4.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.